Cited by 6,763Computational Drug Discovery MethodsProtein Structure and DynamicsProtein Interaction Studies and Fluorescence Analysis

The DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.

Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Jones, Gareth, Willett, Peter, Glen, Robert C, Leach, Andrew R, Taylor, Robin·1997·Journal of Molecular Biology

DOI 10.1006/jmbi.1996.0897

Open this paper in CoChat — free account

Abstract

Prediction of small molecule binding modes to macromolecules of known three-dimensional structure is a problem of paramount importance in rational drug design (the "docking" problem). We report the development and validation of the program GOLD (Genetic Optimisation for Ligand Docking). GOLD is an automated ligand docking program that uses a genetic algorithm to explore the full range of ligand conformational flexibility with partial flexibility of the protein, and satisfies the fundamental requirement that the ligand must displace loosely bound water on binding. Numerous enhancements and modifications have been applied to the original technique resulting in a substantial increase in the reliability and the applicability of the algorithm. The advanced algorithm has been tested on a dataset of 100 complexes extracted from the Brookhaven Protein DataBank. When used to dock the ligand back into the binding site, GOLD achieved a 71% success rate in identifying the experimental binding mode.

Integrity signals

Registry

Crossref · 10.1006/jmbi.1996.0897

Cites

87 of 87 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Genetic algorithms in search, optimization, and machine learning
(1989) · Choice Reviews Online · doi:10.5860/choice.27-0936 · Cited by 49,178
Adaptation in Natural and Artificial Systems
Holland, J. H. (1992) · The MIT Press eBooks · doi:10.7551/mitpress/1090.001.0001 · Cited by 47,340
Molecular Theory of Gases and Liquids
Hirschfelder, J. O., Curtiss, C. F., & Bird, R. B. (1955) · Physics Today · doi:10.1063/1.3061949 · Cited by 11,445
The protein data bank: A computer-based archival file for macromolecular structures
Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., Kennard, O., Shimanouchi, T., & Tasumi, M. (1977) · Journal of Molecular Biology · doi:10.1016/s0022-2836(77)80200-3 · Cited by 8,574
Molecular theory of gases and liquids
Scott, R. L. (1955) · Journal of Chemical Education · doi:10.1021/ed032p232.2 · Cited by 3,958
Semianalytical treatment of solvation for molecular mechanics and dynamics
Still, W. C., Tempczyk, A., Hawley, R. C., & Hendrickson, T. F. (1990) · Journal of the American Chemical Society · doi:10.1021/ja00172a038 · Cited by 3,653
A Fast Flexible Docking Method using an Incremental Construction Algorithm
Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0477 · Cited by 2,836
Validation of the general purpose tripos 5.2 force field
Clark, M., CRAMER, R. D. I., & Opdenbosch, N. V. (1989) · Journal of Computational Chemistry · doi:10.1002/jcc.540100804 · Cited by 2,803
Analytical molecular surface calculation
Connolly, M. L. (1983) · Journal of Applied Crystallography · doi:10.1107/s0021889883010985 · Cited by 2,521
A geometric approach to macromolecule-ligand interactions
Kuntz, I. D., Blaney, J. M., Oatley, S. J., Langridge, R., & Ferrin, T. E. (1982) · Journal of Molecular Biology · doi:10.1016/0022-2836(82)90153-x · Cited by 2,287

Flagged first, then by citations

Show all 87 references

Research works printed but not linked: 2

Dreyer, 1992, Hydroxyethylene isostere inhibitors of human immunodeficiency virus-I protease, Biochemistry, 31
Padlan, 1985, On the specificity of antibody 3-antigen interactions, Ann. Immunol. (Paris), C136, 271

Sorted by citations

Items 301–400 of 1,019

Structure–Activity Studies on Splitomicin Derivatives as Sirtuin Inhibitors and Computational Prediction of Binding Mode
Neugebauer, R. C., Uciechowska, U., Meier, R., Hruby, H., Valkov, V., Verdin, E. M., Sippl, W., & Jung, M. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm700972e · Cited by 166
DynaDock: A new molecular dynamics‐based algorithm for protein–peptide docking including receptor flexibility
Antes, I. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22629 · Cited by 166
Docking-based inverse virtual screening: methods, applications, and challenges
Xu, X., Huang, M., & Zou, X. (2018) · Biophysics Reports · doi:10.1007/s41048-017-0045-8 · Cited by 165
Development and Benchmarking of Open Force Field v1.0.0—the Parsley Small-Molecule Force Field
Qiu, Y., Smith, D. G. A., Boothroyd, S., Jang, H., Hahn, D. F., Wagner, J., Bannan, C. C., Gokey, T., Lim, V. T., Stern, C., et al. (2021) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c00571 · Cited by 165
How to do an evaluation: pitfalls and traps
Hawkins, P. C. D., Warren, G. L., Skillman, A. G., & Nicholls, A. O. (2008) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9166-3 · Cited by 170
Fragment-based screening using X-ray crystallography and NMR spectroscopy
Jhoti, H., Cleasby, A., Verdonk, M. L., & Williams, G. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.07.010 · Cited by 166
Virtual screening with solvation and ligand-induced complementarity
Schnecke, V., & Kuhn, L. A. (2000) · Perspectives in Drug Discovery and Design · doi:10.1023/a:1008737207775 · Cited by 166
The FHA and BRCT domains recognize ADP-ribosylation during DNA damage responsePreprint
Mo, L., Lu, L., Yang, C., Wang, S., & Yu, X. (2013) · Genes & Development · doi:10.1101/gad.226357.113 · Cited by 178
Comparative Performance of Several Flexible Docking Programs and Scoring Functions: Enrichment Studies for a Diverse Set of Pharmaceutically Relevant Targets
Zhou, Z., Felts, A. K., Friesner, R. A., & Levy, R. M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci7000346 · Cited by 168
Mathematical deep learning for pose and binding affinity prediction and ranking in D3R Grand Challenges
Nguyen, D. D., Cang, Z., Wu, K., Wang, M., Cao, Y., & Wei, G.-W. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-018-0146-6 · Cited by 155
Small-Molecule CD4 Mimics Interact with a Highly Conserved Pocket on HIV-1 gp120
Madani, N., Schön, A., Princiotto, A. M., LaLonde, J. M., Courter, J. R., Soeta, T., Ng, D., Wang, L., Brower, E. T., Xiang, S.-H., et al. (2008) · Structure · doi:10.1016/j.str.2008.09.005 · Cited by 166
An iterative knowledge‐based scoring function to predict protein–ligand interactions: II. Validation of the scoring function
Huang, S., & Zou, X. (2006) · Journal of Computational Chemistry · doi:10.1002/jcc.20505 · Cited by 162
Limitations and lessons in the use of X-ray structural information in drug design
Davis, A. M., St-Gallay, S. A., & Kleywegt, G. J. (2008) · Drug Discovery Today · doi:10.1016/j.drudis.2008.06.006 · Cited by 168
Thiazolidinone–Peptide Hybrids as Dengue Virus Protease Inhibitors with Antiviral Activity in Cell Culture
Nitsche, C., Schreier, V. N., Behnam, M. A. M., Kumar, A., Bartenschlager, R. F. W., & Klein, C. D. P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400828u · Cited by 163
Structure-Based Drug Design Strategies in Medicinal Chemistry
Andricopulo, A. D., Salum, L. B., & Abraham, D. J. (2009) · Current Topics in Medicinal Chemistry · doi:10.2174/156802609789207127 · Cited by 162
Essential considerations for using protein–ligand structures in drug discovery
Warren, G. L., Do, T. D., Kelley, B. P., Nicholls, A. O., & Warren, S. D. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.06.011 · Cited by 161
Integrating Structure-Based and Ligand-Based Approaches for Computational Drug Design
Wilson, G. L., & Lill, M. A. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.18 · Cited by 167
Structure-Based Virtual Screening for Ligands of G Protein–Coupled Receptors: What Can Molecular Docking Do for You?
Ballante, F., Kooistra, A. J., Kampen, S., de Graaf, C., & Carlsson, J. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000246 · Cited by 169
The sensitivity of the results of molecular docking to induced fit effects: Application to thrombin, thermolysin and neuraminidase
Murray, C. W., Baxter, C. A., & Frenkel, A. D. (1999) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008015827877 · Cited by 161
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
Cozza, G., Mazzorana, M., Papinutto, E., Bain, J., Elliott, M., Maira, G. D., Gianoncelli, A., Pagano, M. A., Sarno, S., Ruzzene, M., et al. (2009) · Biochemical Journal · doi:10.1042/bj20090069 · Cited by 160
POSIT: Flexible Shape-Guided Docking For Pose Prediction
Kelley, B. P., Brown, S. P., Warren, G. L., & Muchmore, S. W. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5b00142 · Cited by 163
Glossary of terms used in computational drug design, part II (IUPAC Recommendations 2015)
Martin, Y. C., Abagyan, R. A., Ferenczy, G. G., Gillet, V. J., Oprea, T. I., Ulander, J., Winkler, D. A., & Zefirov, N. S. (2016) · Pure and Applied Chemistry · doi:10.1515/pac-2012-1204 · Cited by 161
Evaluation of a flavonoids library for inhibition of pancreatic α-amylase towards a structure–activity relationship
Proença, C., Freitas, M., Ribeiro, D., Tomé, S. M., Oliveira, E. F., Viegas, M. F., Araújo, A. N., Ramos, M. J., Silva, A. M. S., Fernandes, P. A., et al. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1558221 · Cited by 169
Bias, reporting, and sharing: computational evaluations of docking methods
Jain, A. N. (2007) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-007-9151-x · Cited by 165
Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
Kumalo, H., Bhakat, S., & Soliman, M. (2015) · Molecules · doi:10.3390/molecules20021984 · Cited by 158
Dialkylresorcinols as bacterial signaling molecules
Brameyer, S., Kresovic, D., Bode, H. B., & Heermann, R. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417685112 · Cited by 158
Scoring Functions for Protein-Ligand Binding Affinity Prediction Using Structure-based Deep Learning: A Review
Meli, R., Morris, G. M., & Biggin, P. C. (2022) · Frontiers in Bioinformatics · doi:10.3389/fbinf.2022.885983 · Cited by 176
Low-mode conformational search elucidated: Application to C39H80 and flexible docking of 9-deazaguanine inhibitors into PNP
Kolossv�ry, I., & Guida, W. C. (1999) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(19991130)20:15 · Cited by 158
Towards Accurate Free Energy Calculations in Ligand Protein-Binding Studies
Steinbrecher, T. B., & Labahn, A. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790514453 · Cited by 159
Hierarchical virtual screening approaches in small molecule drug discovery
Kumar, A., & Zhang, K. Y. J. (2014) · Methods · doi:10.1016/j.ymeth.2014.07.007 · Cited by 161
Knowledge-based interaction potentials for proteins
Rojnuckarin, A., & Subramaniam, S. (1999) · Proteins Structure Function and Bioinformatics · doi:10.1002/(sici)1097-0134(19990701)36:1 · Cited by 59
A Quantum Mechanics-Based Scoring Function: Study of Zinc Ion-Mediated Ligand Binding
Raha, K., & Merz, K. M. (2004) · Journal of the American Chemical Society · doi:10.1021/ja038496i · Cited by 156
Gatekeeper Mutations Mediate Resistance to BRAF-Targeted Therapies
Whittaker, S. R., Kirk, R., Hayward, R., Zambon, A., Virós, A., Cantariño, N., Affolter, A., Nourry, A., Niculescu‐Duvaz, D., Springer, C. J., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000758 · Cited by 158
Machine learning in computational docking
Khamis, M. A., Gomaa, W. E., & Ahmed, W. (2015) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2015.02.002 · Cited by 158
Structure-Based Virtual Screening Approach for Discovery of Covalently Bound Ligands
Warshaviak, D. T., Golan, G., Borrelli, K. W., Zhu, K., & Kalid, O. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500175r · Cited by 156
Inhibition of Protein Kinase CK2 by Flavonoids and Tyrphostins. A Structural Insight
Lolli, G., Cozza, G., Mazzorana, M., Tibaldi, E. V., Cesaro, L., Donella‐Deana, A., Meggio, F., Venerando, A., Franchin, C., Sarno, S., et al. (2012) · Biochemistry · doi:10.1021/bi300531c · Cited by 155
Comparative Evaluation of Covalent Docking Tools
Scarpino, A., Ferenczy, G. G., & Keserű, G. M. (2018) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00228 · Cited by 155
A Combination of Docking, QM/MM Methods, and MD Simulation for Binding Affinity Estimation of Metalloprotein Ligands
Khandelwal, A., Lukáčová, V., Çömez, D., Kroll, D. M., Raha, S., & Baláž, Š. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049050v · Cited by 153
Adenosine Mimetics as Inhibitors of NAD+-Dependent Histone Deacetylases, from Kinase to Sirtuin Inhibition
Trapp, J., Jochum, A., Meier, R., Saunders, L. R., Marshall, B. L., Kunick, C., Verdin, E. M., Goekjian, P. G., Sippl, W., & Jung, M. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060118b · Cited by 153
Identification of Ellagic Acid as Potent Inhibitor of Protein Kinase CK2: A Successful Example of a Virtual Screening Application
Cozza, G., Bonvini, P., Zorzi, E., Poletto, G., Pagano, M. A., Sarno, S., Donella‐Deana, A., Zagotto, G., Rosolen, A., Pinna, L. A., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060112m · Cited by 153
An Acetylation/Deacetylation-SUMOylation Switch through a Phylogenetically Conserved ψKXEP Motif in the Tumor Suppressor HIC1 Regulates Transcriptional Repression Activity
Stankovic‐Valentin, N., Deltour, S., Seeler, J.-S., Pinte, S., Vergoten, G., Guérardel, C., Dejean, A., & Leprince, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01098-06 · Cited by 153
Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB)
Arikawa, Y., Nishida, H., Kurasawa, O., Hasuoka, A., Hirase, K., Inatomi, N., Hori, Y., Matsukawa, J., Imanishi, A., Kondo, M., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300318t · Cited by 153
Development of Polarizable Models for Molecular Mechanical Calculations I: Parameterization of Atomic Polarizability
Wang, J., Cieplak, P., Li, J., Hou, T., Luo, R., & Duan, Y. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp112133g · Cited by 153
Docking Studies on DNA Intercalators
Gilad, Y., & Senderowitz, H. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400352t · Cited by 153
Integrated Approach to Structure-Based Enzymatic Drug Design: Molecular Modeling, Spectroscopy, and Experimental Bioactivity
Honarparvar, B., Govender, T., Maguire, G. E. M., Soliman, M. E. S., & Kruger, H. G. (2013) · Chemical Reviews · doi:10.1021/cr300314q · Cited by 163
Natural Product Micheliolide (MCL) Irreversibly Activates Pyruvate Kinase M2 and Suppresses Leukemia
Li, J., Li, S., Guo, J., Li, Q., Long, J., Ma, C., Ding, Y., Yan, C., Li, L., Wu, Z., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00241 · Cited by 155
Application of Computational Biology and Artificial Intelligence in Drug Design
Zhang, Y., Luo, M., Wu, P., Wu, S., Lee, T.-Y., & Bai, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113568 · Cited by 167
Analysis of multiple compound–protein interactions reveals novel bioactive molecules
Yabuuchi, H., Niijima, S., Takematsu, H., Ida, T., Hirokawa, T., Hara, T., Ogawa, T., Minowa, Y., Tsujimoto, G., & Okuno, Y. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.5 · Cited by 153
Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents
Dong, G., Sheng, C., Wang, S., Miao, Z., Yao, J., & Zhang, W. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100387d · Cited by 151
Searching Techniques for Databases of Two- and Three-Dimensional Chemical Structures
Willett, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0582165 · Cited by 151
Molecular docking and molecular dynamics simulation
Singh, S., Baker, Q. B., & Singh, D. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-89775-4.00014-6 · Cited by 151
Molecular Dynamics Simulation and Binding Studies of β-Sitosterol with Human Serum Albumin and Its Biological Relevance
Sudhamalla, B., Gokara, M., Ahalawat, N., Damu, A. G., & Subramanyam, R. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp102730p · Cited by 150
Structure Based Development of Phenylimidazole-Derived Inhibitors of Indoleamine 2,3-Dioxygenase
Kumar, S., Jaller, D., Patel, B., LaLonde, J. M., DuHadaway, J. B., Malachowski, W. P., Prendergast, G. C., & Muller, A. J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800512z · Cited by 150
Interaction Studies of Coumaroyltyramine with Human Serum Albumin and Its Biological Importance
Neelam, S., Gokara, M., Sudhamalla, B., Damu, A. G., & Subramanyam, R. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp910156k · Cited by 149
Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
Ekins, S., Chang, C., Mani, S., Krasowski, M. D., Reschly, E. J., Iyer, M., Kholodovych, V. V., Ai, N., Welsh, W. J., Sinz, M., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038398 · Cited by 151
Combinatorial Library Design Using a Multiobjective Genetic Algorithm
Gillet, V. J., Khatib, W., Willett, P., Fleming, P. J., & Green, D. V. S. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci010375j · Cited by 149
Target-Based Approach to Inhibitors of Histone Arginine Methyltransferases
Spannhoff, A., Heinke, R., Bauer, I., Trojer, P., Metzger, E., Gust, R., Schüle, R., Brosch, G., Sippl, W., & Jung, M. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm061250e · Cited by 148
Assessment of programs for ligand binding affinity prediction
Kim, R., & Skolnick, J. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20893 · Cited by 148
Structure‐Based Approaches to Target Fishing and Ligand Profiling
Rognan, D. (2010) · Molecular Informatics · doi:10.1002/minf.200900081 · Cited by 154
General Multiobjective Force Field Optimization Framework, with Application to Reactive Force Fields for Silicon Carbide
Jaramillo-Botero, A., Naserifar, S., & Goddard, W. A. (2014) · Journal of Chemical Theory and Computation · doi:10.1021/ct5001044 · Cited by 147
Machine‐learning scoring functions for structure‐based drug lead optimization
Li, H., Sze, K., Lü, G., & Ballester, P. J. (2020) · Wiley Interdisciplinary Reviews Computational Molecular Science · doi:10.1002/wcms.1465 · Cited by 150
Small-Molecule Inhibitors of the MDM2-p53 Protein−Protein Interaction Based on an Isoindolinone Scaffold
Hardcastle, I. R., Ahmed, S. U., Atkins, H., Farnie, G., Golding, B. T., Griffin, R. J., Guyenne, S., Hutton, C., Källblad, P., Kemp, S. J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0601194 · Cited by 149
Atomistic Simulations of Membrane Ion Channel Conduction, Gating, and Modulation
Flood, E., Boiteux, C., Lev, B. B., Vorobyov, I. V., & Allen, T. W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00630 · Cited by 146
Molecular docking in organic, inorganic, and hybrid systems: a tutorial review
Mohanty, M., & Mohanty, P. S. (2023) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-023-03076-1 · Cited by 174
Receptor-based virtual screening protocol for drug discovery
Cerqueira, N. M. F. S. A., Gesto, D., Oliveira, E. F., Santos‐Martins, D., Brás, N. F., Sousa, S. F., Fernandes, P. A., & Ramos, M. J. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.05.011 · Cited by 151
ASEDock-Docking Based on Alpha Spheres and Excluded Volumes
Goto, J.-I., Kataoka, R., Muta, H., & Hirayama, N. (2008) · Journal of Chemical Information and Modeling · doi:10.1021/ci700352q · Cited by 144
Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand–protein inverse docking approach
Chen, Y., & Ung, C. Y. (2001) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00109-7 · Cited by 145
Application of Fragment Screening by X-ray Crystallography to β-Secretase
Murray, C. W., Callaghan, O., Chessari, G., Cleasby, A., Congreve, M., Frederickson, M., Hartshorn, M. J., McMenamin, R. L., Patel, S., & Wallis, N. G. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0611962 · Cited by 145
Design, Synthesis, and Structure–Activity Relationship Studies of Novel Fused Heterocycles-Linked Triazoles with Good Activity and Water Solubility
Cao, X., Sun, Z., Cao, Y., Wang, R., Cai, T., Chu, W., Hu, W., & Yang, Y. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm4016284 · Cited by 145
In Silico Exploration of the Molecular Mechanism of Clinically Oriented Drugs for Possibly Inhibiting SARS-CoV-2’s Main Protease
Huynh, T., Wang, H., & Luan, B. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c00994 · Cited by 148
Attracting Cavities 2.0: Improving the Flexibility and Robustness for Small-Molecule Docking
Röhrig, U. F., Goullieux, M., Bugnon, M., & Zoete, V. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00054 · Cited by 159
AstexViewerTM †: a visualisation aid for structure-based drug design
Hartshorn, M. J. (2002) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1023813504011 · Cited by 145
Parameter Estimation for Scoring Protein−Ligand Interactions Using Negative Training Data
Pham, T. A., & Jain, A. N. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050040j · Cited by 147
Hierarchical Docking of Databases of Multiple Ligand Conformations
Lorber, D. M., & Shoichet, B. K. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026054637683 · Cited by 148
VISCANA: Visualized Cluster Analysis of Protein−Ligand Interaction Based on the ab Initio Fragment Molecular Orbital Method for Virtual Ligand Screening
Amari, S., Aizawa, M., Zhang, J., Fukuzawa, K., Mochizuki, Y., Iwasawa, Y., Nakata, K., Chuman, H., & Nakano, T. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci050262q · Cited by 144
Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
Barbosa, M. L. D. C., Lima, L. M., Tesch, R., Sant’Anna, C. M. R., Totzke, F., Kubbutat, M. H. G., Schächtele, C., Laufer, S., & Barreiro, E. J. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.058 · Cited by 144
Discovery of Two Novel, Small-Molecule Inhibitors of DNA Methylation
Siedlecki, P. S., Boy, R. G., Musch, T., Brueckner, B., Suhai, S., Lyko, F., & Zielenkiewicz, P. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050844z · Cited by 146
Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach
Medina‐Franco, J. L., López-Vallejo, F., Kuck, D., & Lyko, F. (2010) · Molecular Diversity · doi:10.1007/s11030-010-9262-5 · Cited by 143
GAMESS As a Free Quantum-Mechanical Platform for Drug Research
Alexeev, Y., Mazanetz, M. P., Ichihara, O., & Fedorov, D. G. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612804910269 · Cited by 154
Exploring G Protein-Coupled Receptors (GPCRs) Ligand Space via Cheminformatics Approaches: Impact on Rational Drug Design
Basith, S., Cui, M., Macalino, S. J. Y., Park, J., Clavio, N. A. B., Kang, S., & Choi, S. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00128 · Cited by 149
Discovery of Danoprevir (ITMN-191/R7227), a Highly Selective and Potent Inhibitor of Hepatitis C Virus (HCV) NS3/4A Protease
Jiang, Y., Andrews, S. W., Condroski, K. R., Buckman, B. O., Serebryany, V., Wenglowsky, S., Kennedy, A. L., Madduru, M. R., Wang, B., Lyon, M. A., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400164c · Cited by 141
In silico Methods for Design of Kinase Inhibitors as Anticancer Drugs
Gagić, Ž., Ružić, D., Djoković, N., Djikić, T., & Nikolic, K. M. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00873 · Cited by 148
D3R grand challenge 4: blind prediction of protein–ligand poses, affinity rankings, and relative binding free energies
Parks, C. D., Gaieb, Z., Chiu, M. W., Yang, H., Shao, C., Walters, W. P., Jansen, J. M., McGaughey, G. B., Lewis, R. A., Bembenek, S. D., et al. (2020) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-020-00289-y · Cited by 140
Recent advance on PTP1B inhibitors and their biomedical applications
Sharma, B., Xie, L., Yang, F., Wang, W., Zhou, Q., Xiang, M., Zhou, S., Lv, W., Jia, Y., Pokhrel, L., et al. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112376 · Cited by 140
Characterization of the Interaction between Eupatorin and Bovine Serum Albumin by Spectroscopic and Molecular Modeling Methods
Xu, H., Yao, N., Xu, H., Wang, T., Li, G., & Li, Z. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714185 · Cited by 140
Synthesis, characterization and molecular docking studies of substituted 4-coumarinylpyrano[2,3-c]pyrazole derivatives as potent antibacterial and anti-inflammatory agents
Chougala, B. M., Samundeeswari, S., Holiyachi, M., Shastri, L. A., Dodamani, S., Jalalpure, S. S., Dixit, S. R., Joshi, S. D., & Sunagar, V. A. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.021 · Cited by 140
Functional aspects of the heme bound hemophore HasA by structural analysis of various crystal forms
Arnoux, P., Haser, R., Izadi‐Pruneyre, N., Lecroisey, A., & Czjzek, M. (2000) · Proteins Structure Function and Bioinformatics · doi:10.1002/1097-0134(20001101)41:2 · Cited by 43
Synthesis and Target Identification of Hymenialdisine Analogs
Wan, Y., Hur, W., Cho, C. Y., Liu, Y., Adrian, F. J., Lozach, O., Bach, S., Mayer, T., Fabbro, D., Meijer, L., et al. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.01.015 · Cited by 140
Interaction of Virstatin with Human Serum Albumin: Spectroscopic Analysis and Molecular Modeling
Chatterjee, T., Pal, A., Dey, S., Chatterjee, B. K., & Chakrabarti, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037468 · Cited by 139
How to Improve Docking Accuracy of AutoDock4.2: A Case Study Using Different Electrostatic Potentials
Hou, X., Du, J., Zhang, J., Du, L., Fang, H., & Li, M. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300417y · Cited by 139
Virtual Screening Algorithms in Drug Discovery: A Review Focused on Machine and Deep Learning Methods
de Oliveira, T. A., da Silva, M. P., Maia, E. H. B., da Silva, A. M., & Taranto, A. G. (2023) · Drugs and Drug Candidates · doi:10.3390/ddc2020017 · Cited by 159
“The CSA performance is described in Shin [138], which evaluates two existing docking programs, GOLD [139] and AutoDock [140], on the Astex diverse set.”
Method
Synthesis and biological evaluation of α-ketoamides as inhibitors of the Dengue virus protease with antiviral activity in cell-culture
Steuer, C., Gege, C., Fischl, W., Heinonen, K., Bartenschlager, R. F. W., & Klein, C. D. P. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.05.015 · Cited by 138
Design, synthesis and molecular docking study of novel quinoxalin-2(1H)-ones as anti-tumor active agents with inhibition of tyrosine kinase receptor and studying their cyclooxygenase-2 activity
Galal, S. A., Khairat, S. H. M., Ragab, F. A. F., Abdelsamie, A. S., Ali, M. M., Soliman, S. M., Mortier, J., Wolber, G., & Diwani, H. I. E. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.048 · Cited by 137
Predicting Drug Metabolism: A Site of Metabolism Prediction Tool Applied to the Cytochrome P450 2C9
Zamora, I., Afzelius, L., & Cruciani, G. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm021104i · Cited by 138
A genetic algorithm for the identification of conformationally invariant regions in protein molecules
Schneider, T. R. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444901019291 · Cited by 137
Molecular Docking Screens Using Comparative Models of Proteins
Fan, H., Irwin, J. J., Webb, B. M., Klebe, G., Shoichet, B. K., & Sali, A. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9003706 · Cited by 135
Inclusion of Solvation and Entropy in the Knowledge-Based Scoring Function for Protein−Ligand Interactions
Huang, S., & Zou, X. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci9002987 · Cited by 143
iScreen: world’s first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan
Tsai, T.-Y., Chang, K.-W., & Chen, C. Y. (2011) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-011-9438-9 · Cited by 135
CovalentDock: Automated covalent docking with parameterized covalent linkage energy estimation and molecular geometry constraints
Ouyang, X., Zhou, S., Su, C. T. T., Ge, Z., Li, R., & Kwoh, C. K. (2013) · Journal of Computational Chemistry · doi:10.1002/jcc.23136 · Cited by 134
Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease
Ghosh, A. K., Takayama, J., Aubin, Y., Ratia, K. M., Chaudhuri, R., Báez-Santos, Y. M., Sleeman, K., Coughlin, M. M., Nichols, D. B., Mulhearn, D. C., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900611t · Cited by 134

Authors: Jones, G., Willett, P., Glen, R. C., Leach, A. R., & Taylor, R.
Affiliations: University of Sheffield (GB)
Wellcome Trust (GB)
Cambridge Crystallographic Data Centre (GB)
Corresponding author: Jones, Gareth
ORCID: Jones, Gareth
Willett, Peter
Glen, Robert C
Leach, Andrew R
Taylor, Robin
Venue: Journal of Molecular Biology
Publisher: Elsevier BV
Published: 1997-04
Volume: 267
Issue: 3
Pages: 727-748
ISSN: 0022-2836 (ISSN-L)
DOI: 10.1006/jmbi.1996.0897
OpenAlex: W2050456292
Cited by: 6,763
References: 87
Citations by year: 2026: 244 · 2025: 332 · 2024: 356 · 2023: 361 · 2022: 383 · 2021: 414 · 2020: 394 · 2019: 351 · 2018: 327 · 2017: 270 · 2016: 248 · 2015: 234 · 2014: 237 · 2013: 248 · 2012: 274
Type: book review
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Journal of Molecular Biology (publishedVersion)
PubMed (publishedVersion)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords: protein-ligand docking, genetic algorithm, flexible docking, protein-ligand complex, ligand conformational flexibility, rational drug design, binding mode prediction
MeSH terms: Algorithms, Binding Sites, Computer Simulation, Humans, Ligands, Models, Genetic, Models, Molecular, NADP, Protein Binding, Protein Conformation, Proteins, Tetrahydrofolate Dehydrogenase, Crystallography, X-Ray

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Development and validation of a genetic algorithm for flexible docking 1 1Edited by F. E. Cohen

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks